Anto Pavlovic

1.5k total citations · 1 hit paper
6 papers, 726 citations indexed

About

Anto Pavlovic is a scholar working on Neurology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anto Pavlovic has authored 6 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 3 papers in Pharmacology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anto Pavlovic's work include Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Cannabis and Cannabinoid Research (3 papers) and Barrier Structure and Function Studies (2 papers). Anto Pavlovic is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Cannabis and Cannabinoid Research (3 papers) and Barrier Structure and Function Studies (2 papers). Anto Pavlovic collaborates with scholars based in Switzerland, Germany and United States. Anto Pavlovic's co-authors include Burkhard Becher, Felix J. Hartmann, Frank L. Heppner, Bettina Schreiner, Jonathan Kipnis, Melanie Greter, Sebastian G. Utz, Doron Merkler, Dunja Mrdjen and Brian Leung and has published in prestigious journals such as Immunity, Frontiers in Immunology and Neuropharmacology.

In The Last Decade

Anto Pavlovic

6 papers receiving 724 citations

Hit Papers

High-Dimensional Single-Cell Mapping of Central Nervous S... 2018 2026 2020 2023 2018 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anto Pavlovic Switzerland 3 541 351 139 131 93 6 726
Hannah Van Hove Belgium 7 687 1.3× 506 1.4× 238 1.7× 90 0.7× 76 0.8× 10 1.0k
Dominic Mai Germany 2 792 1.5× 561 1.6× 214 1.5× 121 0.9× 82 0.9× 2 1.0k
Alexander H. De Haas Netherlands 11 495 0.9× 288 0.8× 134 1.0× 113 0.9× 61 0.7× 11 757
Hilmar R. J. van Weering Netherlands 11 422 0.8× 241 0.7× 104 0.7× 96 0.7× 54 0.6× 15 688
Saskia M. Burm Netherlands 10 332 0.6× 259 0.7× 180 1.3× 70 0.5× 44 0.5× 20 599
Adam D. Kovac Germany 9 438 0.8× 272 0.8× 119 0.9× 71 0.5× 60 0.6× 10 695
Sebastian Werneburg Germany 11 312 0.6× 226 0.6× 336 2.4× 65 0.5× 43 0.5× 12 732
Philippa Richardson United Kingdom 3 451 0.8× 271 0.8× 77 0.6× 99 0.8× 46 0.5× 4 529
Wiebke Mildenberger Switzerland 5 338 0.6× 236 0.7× 120 0.9× 39 0.3× 43 0.5× 5 536
Jillian C. Nissen United States 12 277 0.5× 180 0.5× 139 1.0× 62 0.5× 35 0.4× 16 497

Countries citing papers authored by Anto Pavlovic

Since Specialization
Citations

This map shows the geographic impact of Anto Pavlovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anto Pavlovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anto Pavlovic more than expected).

Fields of papers citing papers by Anto Pavlovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anto Pavlovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anto Pavlovic. The network helps show where Anto Pavlovic may publish in the future.

Co-authorship network of co-authors of Anto Pavlovic

This figure shows the co-authorship network connecting the top 25 collaborators of Anto Pavlovic. A scholar is included among the top collaborators of Anto Pavlovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anto Pavlovic. Anto Pavlovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Zheng, Ming‐Qiang, Jiwei Gu, Claudia Keller, et al.. (2024). Exploration of (R)-[11C]YH168 as a PET tracer for imaging monoacylglycerol lipase in the brain: from mice to non-human primates. European Journal of Nuclear Medicine and Molecular Imaging. 52(4). 1556–1565. 1 indexed citations
2.
Pavlovic, Anto, et al.. (2024). Astrocyte‐derived factors regulate CNS myelination. Glia. 72(11). 2038–2060. 2 indexed citations
3.
Guadalupi, Livia, Georgia Mandolesi, Valentina Vanni, et al.. (2024). Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis. Neuropharmacology. 252. 109940–109940. 6 indexed citations
4.
Krämer, Stefanie D., Uwe Grether, Matthias Wittwer, et al.. (2023). Identification of (R)-[18F]YH134 for Monoacylglycerol Lipase Neuroimaging and Exploration of Its Use for Central Nervous System and Peripheral Drug Development. Journal of Nuclear Medicine. 65(2). 300–305. 1 indexed citations
5.
Pavlovic, Anto, et al.. (2021). CD22 Blockage Restores Age-Related Impairments of Microglia Surveillance Capacity. Frontiers in Immunology. 12. 684430–684430. 27 indexed citations
6.
Mrdjen, Dunja, Anto Pavlovic, Felix J. Hartmann, et al.. (2018). High-Dimensional Single-Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease. Immunity. 48(2). 380–395.e6. 689 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026